Autoantibodies in Neoplasia. An Unresolved Enigma
Authors
Affiliations
One hundred sixty-four sera samples of patients with malignant diseases were analyzed for the presence of autoantibodies to ssDNA, dsDNA, poly(I), Poly(G), cardiolipin, histones, RNP, Sm, Ro(SSA), and La (SSB). No distinction could be made between these patients and a comparative group composed of age-adjusted healthy subjects when measuring antibody levels to these autoantigens by the ELISA technique. This finding remained valid after further subgrouping of the patients according to age, sex, and histologic origin of the tumor. The authors conclude that in contrast to the known clinical coexistence of neoplasia in autoimmune states, there is no increased incidence of antinuclear autoantibodies in malignant conditions.
Rugiene R, Dadoniene J, Aleknavicius E, Tikuisis R, Distler J, Schett G Clin Rheumatol. 2011; 30(3):373-80.
PMID: 21225302 DOI: 10.1007/s10067-010-1676-z.
Malleson P, Mackinnon M, Sailer-Hoeck M, Spencer C Pediatr Rheumatol Online J. 2010; 8:27.
PMID: 20961429 PMC: 2987328. DOI: 10.1186/1546-0096-8-27.
Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.
Sapir T, Shoenfeld Y Clin Rev Allergy Immunol. 2006; 29(3):307-10.
PMID: 16391406 DOI: 10.1385/CRIAI:29:3:307.
Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
Tomkiel J, Alansari H, Tang N, Virgin J, Yang X, VandeVord P Clin Cancer Res. 2002; 8(3):752-8.
PMID: 11895905 PMC: 5604237.
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.
Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y Ann Rheum Dis. 2001; 60(5):433-41.
PMID: 11302861 PMC: 1753641. DOI: 10.1136/ard.60.5.433.